Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Advanced Medical Solutions ( (GB:AMS) ) has shared an update.
Advanced Medical Solutions Group plc has confirmed that as of 31 December 2025 its issued share capital consists of 219,556,971 ordinary shares of 5p each, all carrying voting rights, with no shares held in treasury. This updated total voting rights figure provides the reference denominator shareholders must use to assess and report any notifiable holdings or changes under the UK Financial Conduct Authority’s disclosure and transparency requirements, ensuring continued regulatory compliance and clarity over the company’s equity base for investors and other market participants.
The most recent analyst rating on (GB:AMS) stock is a Hold with a £247.00 price target. To see the full list of analyst forecasts on Advanced Medical Solutions stock, see the GB:AMS Stock Forecast page.
Spark’s Take on GB:AMS Stock
According to Spark, TipRanks’ AI Analyst, GB:AMS is a Neutral.
Advanced Medical Solutions shows strong revenue growth and a solid capital structure, but faces challenges with declining profitability margins. Technical indicators suggest a positive trend, though valuation metrics indicate potential overvaluation. Recent corporate events highlight growth potential through strategic acquisitions and investor engagement.
To see Spark’s full report on GB:AMS stock, click here.
More about Advanced Medical Solutions
Advanced Medical Solutions Group plc is a world-leading independent developer and manufacturer of innovative tissue-healing technologies, supplying surgical products such as tissue adhesives, sutures, haemostats, internal fixation devices and sealants under brands including LiquiBand, RESORBA, LiquiBandFix8, LIQUIFIX, Peters Surgical, Ifabond, Vitalitec and Seal-G. The group also provides wound care dressings via its ActivHeal brand and white-label arrangements, has expanded through multiple acquisitions since 2019, manufactures across Europe, Asia and Israel, sells globally via partners and direct sales forces, operates R&D hubs in several countries, and employs more than 1,600 staff.
Average Trading Volume: 714,735
Technical Sentiment Signal: Buy
Current Market Cap: £471.5M
See more insights into AMS stock on TipRanks’ Stock Analysis page.